0 Комментарии
0 Поделились
13 Просмотры
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Статьи пользователей
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Endocrinology Biosimilars Market Potential: Size, Share, Trends, and Future Outlook"Global Demand Outlook for Executive Summary Endocrinology Biosimilars Market Size and Share The global endocrinology biosimilars market size was valued at USD 297 Million in 2025 and is expected to reach USD 632.1 Million by 2033, at a CAGR of 9.90% during the forecast period In order to make smart decisions about budgeting, Market strategies, product...0 Комментарии 0 Поделились 844 Просмотры
-
Endocrinology Biosimilars market Research Report: Size, Share, Growth Factors, Trends & Forecast"Endocrinology Biosimilars Market Summary: According to the latest report published by Data Bridge Market Research, the Endocrinology Biosimilars Market The global endocrinology biosimilars market size was valued at USD 297 Million in 2025 and is expected to reach USD 632.1 Million by 2033, at a CAGR of 9.90% during the forecast period Endocrinology...0 Комментарии 0 Поделились 597 Просмотры
-
Biosimilars Market Poised for Strong Growth Over the Forecast PeriodThe biosimilars market has moved from being a niche segment of the pharmaceutical industry to a strategic pillar of global healthcare systems. As biologic drugs lose patent protection and healthcare budgets tighten, biosimilars are no longer viewed as “alternatives” but as essential tools for improving patient access and system sustainability. This article...0 Комментарии 0 Поделились 2Кб Просмотры
-
Biosimilars Market: Global Industry Overview and DynamicsIn the high-stakes world of modern medicine, we are currently witnessing a structural realignment of the pharmaceutical industry. If the early 2010s were defined by the "patent cliff" of small-molecule blockbusters like Lipitor, 2026 marks the dawn of a far more complex era. This is the year of the biological "super-cliff," where the Biosimilars Market 2026 is poised to bridge the gap...0 Комментарии 0 Поделились 490 Просмотры
-
Biosimilars Market: Growth Drivers and ChallengesIn the high-stakes world of modern medicine, we are currently witnessing a structural realignment of the pharmaceutical industry. If the early 2010s were defined by the "patent cliff" of small-molecule blockbusters like Lipitor, 2026 marks the dawn of a far more complex era. This is the year of the biological "super-cliff," where the Biosimilars Market 2026 is poised to bridge the gap...0 Комментарии 0 Поделились 538 Просмотры
-
Biosimilars Market: Transforming Global Healthcare with Affordable Biologic Alternatives To Forecast 2025-2032The biosimilars market Size is rapidly emerging as one of the most transformative segments within the pharmaceutical industry. As healthcare systems worldwide grapple with rising costs and growing demand for advanced therapies, biosimilars offer a promising solution by providing cost-effective alternatives to expensive biologic drugs. With patents for several blockbuster biologics...0 Комментарии 0 Поделились 536 Просмотры
-
Bone Health Resilience: The 2026 Competitive Dynamics of Denosumab Biosimilars in Osteoporosis Care"Executive Summary Denosumab Market Research: Share and Size Intelligence Data Bridge Market Research analyses that the global denosumab market which was USD 2,892.17 million in 2022, would rocket up to USD 7,109.92 million by 2030, and is expected to undergo a CAGR of 11.9% during the forecast period. The all-inclusive Denosumab Market report is the best to know the trends...0 Комментарии 0 Поделились 903 Просмотры
-
The Biologic Pivot: How Adalimumab Biosimilars are Redefining 2026 Market Access and Patient Affordability"Latest Insights on Executive Summary Adalimumab Biosimilar Market Market Share and Size Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The market insights gained through this keyword market research analysis...0 Комментарии 0 Поделились 998 Просмотры
-
The Savings Surge: How Oncology Biosimilars are Transforming Cancer Care Economics in 2026"Latest Insights on Executive Summary Oncology Biosimilars Market Market Share and Size Global oncology biosimilars market size was valued at USD 6.66 billion in 2024 and is projected to reach USD 25.88 billion by 2032, with a CAGR of 18.5% during the forecast period of 2025 to 2032. This Oncology Biosimilars Market Market research report is an absolute overview of the...0 Комментарии 0 Поделились 974 Просмотры
-
Understanding the Expanding Landscape of the Biosimilars MarketThe pharmaceutical landscape is undergoing one of its most significant transformations since the dawn of small-molecule generics. At the heart of this shift is a profound transition toward biologic therapies and, by extension, the highly anticipated waves of biosimilars designed to make these life-saving drugs accessible to a broader demographic. For healthcare administrators, pharmaceutical...0 Комментарии 0 Поделились 205 Просмотры
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Комментарии 0 Поделились 14 Просмотры
-
Global Microbial Fermentation APIs Market Growing at 1.5% CAGR Through 2032According to a new report from Intel Market Research, the global Microbial Fermentation APIs market was valued at USD 27.57 billion in 2024 and is projected to reach USD 30.56 billion by 2032, exhibiting a steady CAGR of 1.5% during the forecast period (2025–2032). This growth is driven by the increasing demand for antibiotics, amino acids, and vitamins, particularly in emerging economies...0 Комментарии 0 Поделились 126 Просмотры
-
Humira Biosimilar Market Size Projected to Reach USD 4.34 Million by 2032According to a new report published by Introspective Market Research, Humira Biosimilar Market by Product Type, Indication, and Distribution Channel, The Global Humira Biosimilar Market Size Was Valued at USD 0.72 Billion in 2023 and is Projected to Reach USD 4.34 Million by 2032, Growing at a CAGR of 22.1%. Introduction / Market Overview The Humira Biosimilar Market is...0 Комментарии 0 Поделились 2Кб Просмотры
-
Prepaid Card Market: Growth Trends, Opportunities, and Future Outlook To Forecast 2024-2032The global prepaid card market has witnessed remarkable growth over the past decade, driven by rapid digital transformation, financial inclusion initiatives, and the rising demand for convenient, secure, and cashless payment solutions. Prepaid cards, which are preloaded with a specific amount of money and used for transactions until the balance is exhausted, have become an integral...0 Комментарии 0 Поделились 509 Просмотры
Расширенные страницы
© 2026 Khajiit Nation
Russian
Russian
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek